MENU
NBIX
AS OF
Nov 19, 11:34 AM (EDT)
Price
$137.66
Change
-$0.97 (-0.70%)
Capitalization
13.82B
84 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
NBIX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Neurocrine Biosciences (NBIX) Ownership - Who owns Neurocrine Biosciences?

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
12780 El Camino Real
Phone
+1 858 617-7600
Employees
1400
Web
https://www.neurocrine.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
13.82B
P/E Ratio
33.08
Total Cash
1.11B
Projected Growth
0.36
Total Debt
428.4M
Revenue
2.68B
Risk (Beta)
0.69
Dividend Yield
N/A
Total Cash/Share
11.18
Total Debt/Equity
N/A
Revenue/Share
26.25 USD as % of share price

Fundamentals

NBIX
Capitalization
13.8B
P/E Ratio
33.08
Risk (Beta)
0.69
Dividend Yield
N/A
Total Cash
1.12B
Total Cash/Share
11.18
Total Debt
428M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
0.36
Revenue/Share (as % of the share price)
26.25%
Revenue
2.68B
ROE
N/A
Book Value
3B
P/B Ratio
4.60
Cash Flow
N/A
Earnings
4.3
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
100K
Current Ratio
3.38
Current Revenue Per Employee
441611.12
Dividends Per Share - Security
N/A
EBITDA
613M
Float
N/A
Float - Current
N/A
Gross Income Margin
98.24
Revenue To Assets
10.97
Shares Held By Institutions
22.3B
Shares Outstanding - Current
99.7M
Total Liabilities
1.26B
Total Volume MTD
N/A
Value
-1
Gain YTD
1.553
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
NBIX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NBIX showed earnings on October 28, 2025. You can read more about the earnings report here.
View AI-Driven Trading for NBIX
A.I. Advisor
published General Information

General Information

a product based biopharmaceutical company

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Biotechnology
Address
12780 El Camino Real
Phone
+1 858 617-7600
Employees
1400
Web
https://www.neurocrine.com